Pharmaceutical Industry in the 1990s

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Case

Reference no. 9-796-058

Subject category: Strategy and General Management

Authors: Greg Keller (Harvard Business School); A McGahan (California Management Review); Jean G McGuire (John Molson School of Business, Concordia University)

Published by: Harvard Business Publishing

Originally published in: 1995

Version: 18 July 1996

Length: 21 pages

Data source: Published sources

Topics: Competition; Corporate strategy; Customer relationship management; Distribution; Industry structure; Mergers & acquisitions

Share a link: https://casecent.re/p/45285

| No reviews for this item

This product has not been used yet

View our pricing guide or login to see prices.

Abstract

Describes the pharmaceutical industry in the 1990s, with particular emphasis on the mergers between American manufacturers and prescription- benefits managers (PBMs). PBMs are distributors with unprecedented access to information on patient and physician characteristics. Students have an opportunity to analyze the mergers using transactions-cost techniques.

Location:

United States

Industry:

Pharmaceuticals

Other setting(s):

1995